TY - JOUR
AU - Kovoor P.
AU - Zaman S.
AU - Taylor A.
AU - Stiles M.
AU - Chow Clara
AB - <p>
The 'Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction' (PROTECT-ICD) trial is an Australian-led multicentre randomised controlled trial targeting prevention of sudden cardiac death in patients who have at least moderately reduced cardiac function following a myocardial infarct (MI). The primary objective of the trial is to assess whether electrophysiological study to guide prophylactic implantation of an implantable cardioverter-defibrillator (ICD) early following MI (first 40 days) will lead to a significant reduction in sudden cardiac death and non-fatal arrhythmia. The secondary objective is to assess the utility of cardiac MRI (CMR) in assessing early myocardial characteristics, and its predictive value for both inducible ventricular tachycardia (VT) at EPS and SCD/ non-fatal arrhythmia at follow-up.
</p>

AD - MonashHEART, Monash Medical Centre, Melbourne, Vic, Australia; Monash University, Melbourne, Vic, Australia.<br/>Department of Cardiology, The Alfred Hospital, Melbourne, Vic, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Vic, Australia.<br/>Waikato Hospital, Hamilton, New Zealand.<br/>Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; The George Institute for Global Health, Sydney, NSW, Australia.<br/>Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. Electronic address: pramesh.kovoor@sydney.edu.au.
AN - 27522511
BT - Heart Lung Circ
CN - [IF]: 1.438
DP - NLM
ET - 2016/08/16
J2 - Heart, lung & circulation
LA - eng
LB - AUS<br/>CDV<br/>FY17
M1 - 11
N1 - Zaman, Sarah<br/>Taylor, Andrew J<br/>Stiles, Martin<br/>Chow, Clara<br/>Kovoor, Pramesh<br/>Review<br/>Australia<br/>Heart Lung Circ. 2016 Nov;25(11):1055-1062. doi: 10.1016/j.hlc.2016.04.007. Epub 2016 May 6.
N2 - <p>
The 'Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction' (PROTECT-ICD) trial is an Australian-led multicentre randomised controlled trial targeting prevention of sudden cardiac death in patients who have at least moderately reduced cardiac function following a myocardial infarct (MI). The primary objective of the trial is to assess whether electrophysiological study to guide prophylactic implantation of an implantable cardioverter-defibrillator (ICD) early following MI (first 40 days) will lead to a significant reduction in sudden cardiac death and non-fatal arrhythmia. The secondary objective is to assess the utility of cardiac MRI (CMR) in assessing early myocardial characteristics, and its predictive value for both inducible ventricular tachycardia (VT) at EPS and SCD/ non-fatal arrhythmia at follow-up.
</p>

PY - 2016
SN - 1444-2892 (Electronic)<br/>1443-9506 (Linking)
SP - 1055
EP - 1062
ST - Heart Lung Circ
T2 - Heart Lung Circ
TI - Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction (PROTECT-ICD): Trial Protocol, Background and Significance
VL - 25
Y2 - FY17
ER -